Ranjith B. Dissanayake
Expertise in
42
conditions

Dr. Ranjith B. Dissanayake

Oncology
1545 Airport Blvd, Ste 2000, 
Pensacola, FL 
Accepting New Patients
Expertise in
42
conditions
1545 Airport Blvd, Ste 2000, 
Pensacola, FL 

Overview

Ranjith Dissanayake, MD, is a hematologist/oncologist at Ascension Sacred Heart in Pensacola, FL. He has a special interest in treating solid tumor malignancies, such as lung, colon and pancreatic cancer, as well as non-Hodgkin's lymphoma. Dr. Dissanayake has expertise in critical care for hematology-oncology patients, immunotherapy treatment, and therapeutics for recurrent cancer. With our multispecialty approach to care, he works with a team of specialists dedicated to your care.

Dr. Dissanayake is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Bone Marrow Aspiration.

Dr. Dissanayake is board certified in The American Board Of Internal Medicine - Hematology. He is actively involved in clinical research, participating in 6 clinical trials. Dr. Dissanayake is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in FL

Board Certifications

The American Board Of Internal Medicine - Hematology

Fellowships

Cook County Hospital - John Stroger Hospital

Hospital Affiliations

Ascension Sacred Heart Hospital Pensacola
Sacred Heart Hospital
Baptist Hospital
Sacred Heart Hospital On The Emerald Coast

Languages Spoken

English
Sindhi
Sinhala

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Ascension Sacred Heart Cancer Center - Pensacola
1545 Airport Blvd, Ste 2000, Pensacola, FL 32504

Additional Areas of Focus

Dr. Dissanayake has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Biological, Drug
Study Drugs: Carboplatin, Nivolumab, Paclitaxel
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required

Baptist Medical Group-Hematology-Oncology

125 Baptist Way Ste 1C, 
Pensacola, FL 
 (1.5 miles away)
448-227-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sherif Ibrahim is an Oncologist practicing medicine in Pensacola, Florida. Dr. Ibrahim is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Heart Tumor, Paget Disease of the Breast, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Ibrahim is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Ascension Sacred Heart Cancer Center - Pensacola

1545 Airport Blvd, Ste 2000, 
Pensacola, FL 
 (0.1 miles away)
850-416-6933
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven L. Decesare, MD, is a board-certified gynecological oncologist at Ascension Sacred Heart in Pensacola, FL. He is a cancer specialist who diagnoses and treats ovarian cancer and female reproductive cancers. Dr. Decesare has a special interest in the detection and treatment of tumors originating in a woman's reproductive organs. He focuses on improving women's health by providing advanced surgical care and medication management for gynecologic cancer. Dr. Decesare is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Virilizing Ovarian Tumor, Hernia Surgery, and Colonoscopy. Dr. Decesare is board certified in The American Board Of Obstetrics And Gynecology - Gynecologic Oncology and The American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology. Dr. Decesare is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

Ascension Sacred Heart Cancer Center - Pensacola

1545 Airport Blvd, Ste 2000, 
Pensacola, FL 
 (0.1 miles away)
850-416-6933
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Yazan M. Alsayed, MD provides expert Medical Oncology care at Ascension Sacred Heart in FL. Schedule your appointment today. Dr. Alsayed is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Alsayed is board certified in The American Board Of Internal Medicine - Medical Oncology. Dr. Alsayed is currently accepting new patients.

Frequently Asked Questions about Dr. Ranjith B. Dissanayake

How do I make an appointment with Dr. Ranjith B. Dissanayake?

You can book an appointment with Dr. Ranjith B. Dissanayake by calling their office at 850-416-6933. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ranjith B. Dissanayake a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ranjith B. Dissanayake is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ranjith B. Dissanayake specialize in?

While Dr. Ranjith B. Dissanayake is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Ranjith B. Dissanayake accept my insurance?

Dr. Ranjith B. Dissanayake accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 850-416-6933 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dissanayake's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 34 Advanced Conditions
    View All 95 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile